Identifying Genetic Causes of IC/BPS

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description expanded, about 6 words
    • Site contact updated
    • Publications: details revised at 1 of 2 entries
    v12
  2. Primary completion date: Dec 31, 2025 to Dec 31, 2030v11 Show 5 more changesShow less
    • Enrollment target: 750 to 1000
    • Study completion date: Dec 31, 2026 to Dec 31, 2030
    • Eligibility criteria revised
    • Publications: 1 to 2
    • Study description shortened, about 3 words
  3. Re-verified, no change to tracked fieldsv10
  4. Enrollment target: 500 to 750
    • Site contact updated
    • Study description expanded, about 5 words
    • Study title shortened, about 1 word
    v9
  5. Eligibility criteria revised
    • Study description expanded, about 12 words
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Primary completion date: Dec 31, 2020 to Dec 31, 2025
    • Study completion date: Dec 31, 2021 to Dec 31, 2026
    • Study site revised
    v7
  2. Study description expanded, about 49 words
    • Eligibility criteria expanded, about 3 words
    v6
  3. Primary completion date: Dec 31, 2020v5 Show 8 more changesShow less
    • Study completion date: Jun 2012 to Dec 31, 2021
    • Start date: Jan 2006 to Jan 15, 2006
    • Eligibility criteria shortened, about 7 words
    • Site contact updated
    • Publications: 2 to 1
    • Study description expanded, about 1 word
    • Collaborators shortened, about 5 words
    • Study title expanded, about 1 word
  4. Study completion date: Jan 2011 to Jun 2012
    • Eligibility criteria expanded, about 2 words
    • Study description expanded, about 3 words
    • Collaborators expanded, about 5 words
    v4
  5. Enrollment target: 100 to 500
    • Study completion date: Jan 2009 to Jan 2011
    • Eligibility criteria expanded, about 10 words
    • Study description expanded, about 25 words
    v3
  6. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Interstitial cystitis (IC), also called Bladder Pain syndrome (BPS) is a common condition with no known cause or cure. Twin studies and family accounts have suggested that the condition may be genetic or passed down (inherited) from one generation to another. In this study, the investigators are collecting genetic material via blood or saliva and medical information from families in North America in an attempt to identify genetic factors that may cause IC/BPS. The investigators are enrolling inviduals with IC/BPS and their family members (family members with and without IC like symptoms). Travel to Boston not required.
Trial Details
NCT Number NCT00389142
Lead Sponsor Boston Children's Hospital
Conditions
(from sponsor)		 Interstitial Cystitis, Bladder Pain Syndrome
Related terms Cystitis, Interstitial, Pelvic Pain
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov